Acadia Pharmaceuticals Inc. ACAD
21.23 USD -0.01 (-0.05%)
At closeNov 6, 2026, 4:50 PM EST
21.23 0.00 0.00%
After hours · Nov 6, 4:50 PM ET
20.59 Day range 21.44
18.62 52-week range 30.57
- YTD
- -20.52%
- 1 year
- -1.94%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.07B | 957.80M | 726.44M | 517.24M | 484.14M | |
| 982.51M | 875.96M | 684.80M | 507.07M | 465.00M | |
| 104.81M | 230.79M | -73.38M | -223.60M | -170.44M | |
| 391.00M | 226.45M | -61.29M | -215.97M | -167.87M | |
| 2.30 | 1.36 | -0.37 | -1.34 | -1.05 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 185.54M | 328.36M | 194.43M | 120.62M | 153.21M | |
| 1.56B | 1.19B | 748.96M | 587.81M | 700.12M | |
| 336.81M | 454.96M | 317.20M | 187.40M | 159.23M | |
| 40.55M | 42.04M | 47.80M | 52.70M | 56.13M | |
| 1.23B | 732.79M | 431.75M | 400.41M | 540.89M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 109.84M | 157.72M | 16.70M | -114.03M | -125.66M | |
| -302.56M | -30.54M | 32.00M | 73.24M | -71.10M | |
| 49.88M | 6.84M | 25.13M | 8.20M | 18.16M | |
| -4.69M | -523.00K | -50.00K | 0 | -1.12M | |
| -142.82M | 133.93M | 73.81M | -32.59M | -178.59M |